and remember when it went from $5.00 ($7.00 in todays dilution), and went to 0.28?
this stock should never have been down to 28c in the first place. especially as stocksa has pointed out that it was on the back of basic formatting errors in FDA submissions
the reality is, as I pointed out a few weeks ago, the charts are not favourable to MSB right now. even as a mid cap with FDA approved product, it is still going to be trading on catalysts like a micro cap.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)